for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Reckitt Benckiser Group Plc

RB.L

Latest Trade

6,000.00GBp

Change

50.00(+0.84%)

Volume

2,303,270

Today's Range

5,930.00

 - 

6,108.00

52 Week Range

5,130.00

 - 

8,020.00

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
5,950.00
Open
5,952.00
Volume
2,303,270
3M AVG Volume
23.00
Today's High
6,108.00
Today's Low
5,930.00
52 Week High
8,020.00
52 Week Low
5,130.00
Shares Out (MIL)
712.77
Market Cap (MIL)
42,766.25
Forward P/E
19.42
Dividend (Yield %)
2.91

Next Event

Dividend For RB. - 101.6000 GBX

Latest Developments

More

Performance Health To Sell Its Biofreeze And Therapearl Brands To Reckitt Benckiser Group Plc

Reckitt Benckiser Announces Sale Of Scholl To Yellow Wood Partners

Reckitt Benckiser FY Adj Diluted EPS 327p

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Reckitt Benckiser Group Plc

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene, post-natal and home products. The Company's segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN). Health, Hygiene, Home and Portfolio Brands categories are split across the geographical segments of ENA and DVM. Its range of hygiene products includes disinfectant cleaners, automatic dishwashing detergents, pest control, depilatory products and acne treatments. The Company's portfolio of brands includes Durex, Mucinex, Scholl, Strepsils, Cillit Bang, Clearasil, Dettol, Harpic, Lysol, Mortein, Veet, Air Wick, Calgon, Queen V, Vanish and Woolite.

Industry

Personal & Household Prods.

Contact Info

103-105 Bath Road

SL1 3UH

United Kingdom

+44.1753.217800

https://www.rb.com

Executive Leadership

Christopher Alan Sinclair

Non-Executive Chairman of the Board

Laxman Narasimhan

Chief Executive Officer, Director

Jeffrey Carr

Chief Financial Officer, Executive Director

Kris Licht

President - Health, Global Chief Customer Officer

Aditya Sehgal

President - Nutrition, President China and E-RB

Key Stats

2.18 mean rating - 22 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2018

12.6K

2019

12.8K

2020

14.0K

2021(E)

13.6K
EPS (GBp)

2018

339.900

2019

349.000

2020

327.000

2021(E)

309.546
Price To Earnings (TTM)
37.61
Price To Sales (TTM)
3.06
Price To Book (MRQ)
4.68
Price To Cash Flow (TTM)
26.32
Total Debt To Equity (MRQ)
115.82
LT Debt To Equity (MRQ)
107.45
Return on Investment (TTM)
4.86
Return on Equity (TTM)
3.64

Latest News

Latest News

Reckitt Benckiser predicts rosy outlook after record 2020

British consumer goods group Reckitt Benckiser expects to maintain strong sales this year, it said on Wednesday as it posted record pandemic-driven sales in 2020 and announced the disposal of its Scholl footcare business.

Breakingviews - Capital Calls: Reckitt cleanup deserves premium

Concise insights on global finance in the Covid-19 era.

Reckitt withdraws $1.4 billion claim against Indivior over U.S. opioid probe

Indivior said on Monday former parent Reckitt Benckiser would withdraw a $1.4 billion claim against the company and it would pay the Dettol-maker $50 million to end a legal battle related to a U.S. probe into opioid addiction.

Reckitt withdraws $1.4 bln claim against Indivior

Indivior said on Monday its former parent Reckitt Benckiser had withdrawn a $1.4 billion claim against the drugmaker as part of a 2019 settlement with U.S. authorities to end a probe into the companies' opioid addiction treatment.

Indivior to 'vigorously defend' Reckitt Benckiser's $1.4 billion claim

British drugmaker Indivior Plc said on Monday it would "vigorously defend" against a 1.07 billion pound ($1.43 billion) legal claim from consumer good maker Reckitt Benckiser Group relating to their demerger agreement.

Reckitt files 1.07 billion pound claim against former unit Indivior

Consumer good maker Reckitt Benckiser earlier this month submitted a 1.07 billion pound ($1.43 billion) claim to the Commercial Court in London against Indivior relating to their demerger agreement, the drug developer said on Friday.

Reckitt files 1.07 bln pound claim against former unit Indivior

Reckitt Benckiser has submitted a 1.07 billion pound claim to the Commercial Court in London against UK-listed drug developer Indivior earlier this month, relating to their demerger agreement, Indivior said on Friday.

Reckitt lifts sales view as coronavirus spurs demand for Dettol, Lysol

Reckitt Benckiser <RB.L> reported a much bigger-than-expected rise in third-quarter sales on Tuesday and raised its full-year outlook, as the coronavirus pandemic lifts demand for cleaning products such as Dettol and Lysol.

FTSE 100 falls as lockdowns, Brexit uncertainty weigh

London's FTSE 100 fell on Tuesday on concerns over tougher coronavirus lockdowns in parts of England and Brexit-related uncertainty, although losses were limited due to upbeat quarterly results from Reckitt Benckiser.

Reckitt Q3 sales up on coronavirus demand for cleaning products

Reckitt Benckiser on Tuesday reported a bigger-than-expected rise in third-quarter sales that were boosted as the coronavirus pandemic spurred demand for cleaning products.

Exclusive: Reckitt kicks off sale of some personal care brands - sources

Consumer goods group Reckitt Benckiser Group <RB.L> is preparing to sell some of its non-core personal care brands, including Veet hair removal cream and Clearasil acne cream, four sources familiar with the matter said on Monday.

Delta teams up with Lysol to innovate on travel hygiene

Delta Air Lines <DAL.N> said on Monday it is teaming up with Reckitt Benckiser Group Plc <RB.L>, the makers of Lysol, to research and develop new disinfecting solutions for high-traffic areas in airports and onboard, with a first focus on airplane lavatories.

Brazilian waste management firm finds cost-cutting users in pandemic

A month-old Brazilian company's machines that use bacteria to break down organic waste has found users among domestic upscale supermarket Natural da Terra, units of Reckitt Benckiser <RB.L> and Siemens AG <SIEGn.DE>, and logistics firm Luft, its chief executive said on Thursday...

U.S. EPA approves use of Lysol Disinfectant Spray against COVID-19

UK-based Reckitt Benckiser Group Plc <RB.L> said on Tuesday that the U.S. Environmental Protection Agency (EPA) has approved use of its Lysol Disinfectant Spray against COVID-19.

Reckitt Benckiser's sales surge on coronavirus disinfectant boom

Reckitt Benckiser <RB.L> achieved record sales growth in the first quarter and predicted a stronger than expected performance in 2020 as customers stocked up on Lysol disinfectants, Mucinex cough syrup and Dettol soap ahead of the coronavirus lockdowns.

London stocks rise on optimism around virus drug, upbeat earnings

UK stock markets rose on Thursday as investors cheered signs of progress in developing a treatment for the novel coronavirus, while Reckitt Benckiser surged after reporting strong demand for its products ahead of the lockdown.

BRIEF-Reckitt Benckiser Posts Record Sales On Disinfectant Boom

* RECKITT - QTRLY REVENUE 3,544 MILLION STG VERSUS 3,157 MILLION STG AS REPORTED A YEAR EARLIER

BRIEF-Reckitt Benckiser Says Co's Disinfectant Products Should Not Be Administered Into Human Body Through Injection, Ingestion, Any Other Route

* RECKITT BENCKISER- CO'S DISINFECTANT PRODUCTS SHOULD NOT BE ADMINISTERED INTO HUMAN BODY THROUGH INJECTION, INGESTION, ANY OTHER ROUTE Source text: https://bit.ly/3cHBvkY Further company coverage:

BRIEF-Reckitt Looks To Up Capacity Of Disinfectants, Sanitisers, Soaps In 2020

* RECKITT BENCKISER - ANNOUNCING LAUNCH OF THE RB FIGHT FOR ACCESS FUND TO IMPROVE ACCESS TO HEALTH, HYGIENE AND NUTRITION FOR ALL

BRIEF-Reckitt Says Not Aware Of Evidence Ibuprofen Impacts Covid-19 Patients

* RECKITT -AWARE OF SOCIAL MEDIA IN FRANCE CONCERNS ON USE OF STEROIDS & NON-STEROIDAL ANTI-INFLAMMATORY PRODUCTS FOR ALLEVIATION OF COVID-19 SYMPTOMS

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up